Following promising results from pre-clinical research and a recent clinical study on stem cell-based therapies for Type 1 diabetes patients, researchers are now focusing on maximising the function and potential of stem cell-based treatments for future patient application.
A team of researchers revealed that stem cells from the human stomach may be transformed into cells that produce insulin in response to rising blood sugar levels, presenting a promising strategy for treating diabetes
Getting a host immune system to accept the presence of implanted insulin-secreting cells could change the lives of the more than 700 million people who have Type 1 diabetes worldwide.